These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33649538)

  • 1. The RanBP2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis.
    Blondel-Tepaz E; Leverve M; Sokrat B; Paradis JS; Kosic M; Saha K; Auffray C; Lima-Fernandes E; Zamborlini A; Poupon A; Gaboury L; Findlay J; Baillie GS; Enslen H; Bouvier M; Angers S; Marullo S; Scott MGH
    Oncogene; 2021 Mar; 40(12):2243-2257. PubMed ID: 33649538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 SUMOylation promotes its nuclear export by facilitating its release from the nuclear export receptor CRM1.
    Santiago A; Li D; Zhao LY; Godsey A; Liao D
    Mol Biol Cell; 2013 Sep; 24(17):2739-52. PubMed ID: 23825024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mdm2-mediated ubiquitination of β-arrestin2 in the nucleus occurs in a Gβγ- and clathrin-dependent manner.
    Zhang X; Min X; Wang S; Sun N; Kim KM
    Biochem Pharmacol; 2020 Aug; 178():114049. PubMed ID: 32450252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination.
    O'Keefe K; Li H; Zhang Y
    Mol Cell Biol; 2003 Sep; 23(18):6396-405. PubMed ID: 12944468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53.
    Carter S; Bischof O; Dejean A; Vousden KH
    Nat Cell Biol; 2007 Apr; 9(4):428-35. PubMed ID: 17369817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination.
    Nie L; Sasaki M; Maki CG
    J Biol Chem; 2007 May; 282(19):14616-25. PubMed ID: 17371868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
    Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
    Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO regulates p21Cip1 intracellular distribution and with p21Cip1 facilitates multiprotein complex formation in the nucleolus upon DNA damage.
    Brun S; Abella N; Berciano MT; Tapia O; Jaumot M; Freire R; Lafarga M; Agell N
    PLoS One; 2017; 12(6):e0178925. PubMed ID: 28582471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex.
    Matunis MJ; Wu J; Blobel G
    J Cell Biol; 1998 Feb; 140(3):499-509. PubMed ID: 9456312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53.
    Boularan C; Scott MG; Bourougaa K; Bellal M; Esteve E; Thuret A; Benmerah A; Tramier M; Coppey-Moisan M; Labbé-Jullié C; Fåhraeus R; Marullo S
    Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18061-6. PubMed ID: 17984062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMO-specific protease 2 in Mdm2-mediated regulation of p53.
    Jiang M; Chiu SY; Hsu W
    Cell Death Differ; 2011 Jun; 18(6):1005-15. PubMed ID: 21183956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of
    Zhang F; Yang J; Cheng Y
    Biomol Biomed; 2024 Oct; 24(6):1620-1636. PubMed ID: 38801243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importin-β and CRM1 control a RANBP2 spatiotemporal switch essential for mitotic kinetochore function.
    Gilistro E; de Turris V; Damizia M; Verrico A; Moroni S; De Santis R; Rosa A; Lavia P
    J Cell Sci; 2017 Aug; 130(15):2564-2578. PubMed ID: 28600321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation.
    Pelisch F; Pozzi B; Risso G; Muñoz MJ; Srebrow A
    J Biol Chem; 2012 Aug; 287(36):30789-99. PubMed ID: 22825850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.
    Gareau JR; Reverter D; Lima CD
    J Biol Chem; 2012 Feb; 287(7):4740-51. PubMed ID: 22194619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.
    Freedman DA; Levine AJ
    Mol Cell Biol; 1998 Dec; 18(12):7288-93. PubMed ID: 9819415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.
    He Y; Yang Z; Zhao CS; Xiao Z; Gong Y; Li YY; Chen Y; Du Y; Feng D; Altman A; Li Y
    Elife; 2021 Jun; 10():. PubMed ID: 34110283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes.
    Miyauchi Y; Yogosawa S; Honda R; Nishida T; Yasuda H
    J Biol Chem; 2002 Dec; 277(51):50131-6. PubMed ID: 12393906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods to Investigate the Nucleocytoplasmic Shuttling Properties of β-Arrestins.
    Blondel-Tepaz E; Guilbert T; Scott MGH
    Methods Mol Biol; 2019; 1957():251-269. PubMed ID: 30919359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.